EveliQure Biotechnologies
PrivateLast Round
Strategic
Mar 20, 2026
Total Funding Raised
$37.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
EveliQure Biotechnologies is a clinical-stage biotechnology company that develops innovative vaccine technology platforms to prevent diarrheal diseases caused by enteric pathogens such as Shigella and ETEC.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EveliQure Biotechnologies Comparables
Compare EveliQure Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scandinavian Biopharma | 87% | |
| Eli Lilly and Company | 82% | |
| MecVax | 79% | |
EveliQure Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 20, 2026 | ||||
| Grant | Sep 9, 2020 | ||||
| VC Round | Jul 2, 2020 | ||||
| Grant | Nov 5, 2019 | ||||
| Grant | Sep 10, 2019 | ||||
Grant | Jan 1, 2019 |
EveliQure Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARAX Capital Partners | VC Round |
| National Institute of Allergy and Infectious Diseases | Grant |
| Austria Wirtschaftsservice | Grant |
| FFG Austrian Research Promotion Agency | Grant |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 44% MoM.
- Mar 20, 2026
Serum Institute of India led the strategic round.
EveliQure Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |